How close are we to Covid-19 vaccines for younger kids?

 

How close are we to Covid-19 vaccines for younger kids?

 

Last week, Pfizer said it had submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but the company has not yet sought emergency use authorization.   This is the first submission of data to the FDA for a Covid-19 vaccine for younger children. The Pfizer/BioNTech vaccine is currently approved for people age 16 and older and has an EUA for people ages 12 to 15.   The FDA’s vaccine advisory committee is scheduled to meet on October 26 to discuss Pfizer’s vaccine for children ages 5 to 11. If the FDA OKs it, the CDC’s vaccine advisers will then meet to consider whether to recommend its use.   Data on the immune response and safety for two more age groups – children ages 2 to 5 and a younger group 6 months to 2 years – are expected "as soon as the fourth quarter of this year," Pfizer said in a news release.   ➕ CDC to pregnant women: Get vaccinated against Covid-19